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the mean total histological score, as well as with medial com- 
partment score (p=0.028, r=0.859 and p=0.033, r=0.847, respec- 
tively). Steady-state mRNA levels of FXlIIA were not detectable 
in either the medial or the lateral compartment until 12 months 
of age, when a low level of expression was detected in the me- 
dial compartment. Concentrations of TG2 in guinea pig synovial 
fluid rose steadily from 7 to 12 months of age and correlated 
significantly with total histological score (p=0.03, r=0.46). TG2 
concentrations also correlated strongly with synovial fluid COMP 
(p=0.05, r=0.39). The association of TG2 with histological out- 
come remained significant after adjusting for the effects of age, 
weight, and COMP. There was no significant change in the levels 
of SF FXlIIA with age, as well as no correlation with total histo- 
logical score. 
Conclusions: Our results reveal that TG2, but not FXlIIA mRNA 
expression and synovial fluid protein concentrations, reflect his- 
tological OA in the guinea pig model as well as disease pro- 
gression. These findings are consistent with the proposed role 
of TG2 in OA pathogenesis via effects on chondrocyte differenti- 
ation. TG2, expressed by chondrocytes in situ and released into 
the synovial fluid, also serves as a novel and TG family-specific 
biomarker of OA development and progression. 
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The aim of this study was to measure hyaluronic acid (HA) 
turnover in the synovial fluid of normal and degenerate knee joints 
using a novel in vivo labeling method. 
Newly-synthesized HA was labeled in experimental animals by 
administering water enriched with 2H20 , first as an IP injection, 
then as drinking water. Following 24 hours of labeling, synovial 
fluid was collected from the knee joints by lavage, and the HA was 
isolated and analyzed by gas chromatography mass spectrome- 
try. The fraction of synovial fluid HA that was newly-synthesized 
was determined from the incorporation of 2H into N-acetyl glu- 
cosamine. Three animal models of osteoarthritis (OA) were used. 
Guinea pigs were analyzed both at a young age (2 months old) 
and after the onset of spontaneous OA (12 months old). Also, 
experimental OA was induced in one knee of rats by either a sin- 
gle intra-articular injection of the glycolysis inhibitor, monoiodoac- 
etate, or by meniscal tear surgery. Rats were analyzed five days 
after treatment, at which point, degenerative changes could be 
observed histologically. Contralateral knees were used as con- 
trols. 
In all cases, the fractional synthesis of synovial fluid HA was 
higher in aged or treated joints (Fig. 1). 724-8% of synovial fluid 
HA was turned over during the 24 hour labeling period in young 
guinea pigs, whereas older guinea pigs had a fractional synthe- 
sis of 874-7% (n=5-6, p<0.01 ). Monoiodoacetate (MIA) treatment 
led to an 16% increase in the fractional synthesis of the HA in 
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Fig. 1. Effect of experimentally induced OA on fractional synthesis of HA in 
the synovial fluid of the degenerate knee joint. 
the synovial fluid (n=3, p<0.01). Similarly, knees subjected to 
meniscal tear surgery (MNX) exhibited a fractional synthesis of 
HA of 704-1.3%, compared to control knees which had a frac- 
tional synthesis of 564-1.6% (n=2), although the differences were 
not statisically significant (p=0.1). 
The results of this study suggest a correlation between the os- 
teoarthritic hanges induced in these animal models and an in- 
crease in the turnover of the hyaluronan component of the syn- 
ovial fluid in the affected joint. Such an increase in HA may be 
due, in part, to the onset of synovitis, a common feature of os- 
teoarthritis. Indeed, our results may support clinical observations 
that synovitis correlates with OA progression. Since this method 
requires only a representative sampling of synovial fluid, it could 
provide a minimally invasive index of disease progression in hu- 
mans. 
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Aim of Study: Osteoarthritis (OA) is a degenerative joint disease 
characterized by progressive erosion of articular cartilage. Aggre- 
can is an important component of the extracellular matrix and so 
the monitoring of its degradation and formation could be useful in 
monitoring disease activity or the efficacy of treatment with chon- 
droprotective agents. The aim of the present study was to inves- 
tigate the potential of two newly developed immunoassays for the 
assessment of aggrecan metabolism under various experimental 
conditions. 
Methods: Ex vivo cartilage explants were cultured under serum- 
free conditions with either 1) no cytokines, 2) with the cy- 
tokines oncostatin M (OSM) and TNF~, or 3) with the aforemen- 
tioned cytokines plus an MMP-inhibitor, GM6001 101~M. For refer- 
ence purposes, metabolically inactivated cartilage explants were 
also included. The culture medium was replaced every 2nd-3  rd 
day, and assessed for changes in aggrecan metabolism. Aggre- 
can turnover was characterized by two independently developed 
sandwich immuno-assays: 1) Assay G2 employs a monoclonal 
antibody (F78) specific for the G2 domain of aggrecan, 2) Assay 
FFGVG-G2 combining the F78 antibody with a monoclonal anti- 
body (AF28) targeting the epitope 342FFGVG, which is generated 
during MMP digestion at the cleavage site VDIPEN-FFGVG in the 
interglobular domain of aggrecan. 
Results: Ex vivo cartilage explants were exposed to OSM and 
TNF-~ to induce cartilage degradation, which was accompanied 
by a gradual increase in the concentration of FFGVG-G2 from 
day Day 12 (Fig. 1). When the exposure of explants occurred in 
the concomitant presence of GM6001, the release of FFGVG-G2 
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